City page
Hamburg biotech and pharma directory
This page shows why the city matters, which categories are strongest there, and which compliance or quality markers are already visible in public evidence.
Where does this city read strongest?
Therapeutics (2), Tools (1), and Research (1). Most visible records: altona Diagnostics GmbH, Indivumed Therapeutics GmbH, and Topas Therapeutics GmbH.
Which standards and public evidence are already visible?
GLP (1), ISO-13485 (2), and FDA-Inspected (1). Latest review: 24 April 2026. Review cycle: April 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Hamburg.
By category
Hamburg by category
Jump into a category page filtered to this country only.
Full list
Hamburg biotech and pharma directory
5 city records currently match the active filter.
Current review cycle
altona Diagnostics GmbH
HamburgGermanyDiagnostics
Hamburg ISO 13485-certified molecular diagnostics manufacturer building CE-IVD real-time PCR assays for infectious disease, with global distribution through subsidiaries and a historical FDA EUA track record for its RealStar Ebolavirus assay.
- Lead
- Soenke FriedrichsenManaging Director (joint with Hans Kuhn)
- Scale
- Commercial CE-IVD diagnostic manufacturing
Current review cycle
Indivumed Therapeutics GmbH
HamburgGermanyTherapeutics
Hamburg AI and multi-omics precision-oncology therapeutics company, built on the IndivuType cancer database and a global clinical-site network, after the 2023 services and biobank arm divestment to Crown Bioscience.
- Lead
- Hartmut JuhlFounder and Chief Executive Officer
- Scale
- AI-driven target discovery and early compound development
Current review cycle
Topas Therapeutics GmbH
HamburgGermanyTherapeutics
Hamburg clinical-stage biotech developing antigen-specific nanoparticle therapeutics to induce immune tolerance, with TPM502 for celiac disease completing Phase 2a in 2025.
- Lead
- Hugo FryChief Executive Officer
- Scale
- Clinical-stage therapeutics development
Current review cycle
Evotec
HamburgGermanyResearch
Hamburg discovery and development platform spanning integrated R&D, translational biology, and industrialized biotech partnerships.
- Lead
- Dr. Christian WojczewskiChief Executive Officer and Chair of the Management Board
- Scale
- Global research platform
Current review cycle
Eppendorf Group
HamburgGermanyTools
Hamburg life-science instrumentation anchor spanning liquid handling, centrifugation, bioprocess systems, and laboratory automation.
- Lead
- Dr. Christine MunzChief Executive Officer
- Scale
- Global instrument manufacturing
Related briefs
Briefs that mention Hamburg
German Biotech & Pharma Landscape 2026: Heidelberg, Berlin, Mainz
A practical map of the German biotech and pharma landscape in 2026 — 57 operators across Heidelberg, Berlin, Mainz, Hamburg, Munich, and smaller sites, organised by what they actually do and how the pieces connect.
Open briefEuropean Vaccines Landscape 2026: Biodefence, mRNA, Allergen, Infectious Disease
A practical map of the European vaccines sector in 2026 — Bavarian Nordic MVA-BN biodefence, BioNTech and CureVac mRNA, ALK-Abelló allergen immunotherapy, Valneva infectious-disease vaccines, Statens Serum Institut, plus a specialised clinical-stage innovator layer.
Open briefEuropean Drug Discovery Services 2026: CRO, Medicinal Chemistry, ADMET, DMPK
Where to run European drug discovery services in 2026 — Evotec, Selvita, Charles River Finland, Gubra, Admescope, plus a Swiss + Polish + Nordic tool + platform layer for medicinal chemistry, DMPK, ADMET, and translational research.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.